DTIL
Price
$5.50
Change
-$0.18 (-3.17%)
Updated
Apr 24 closing price
Capitalization
58.03M
ORMP
Price
$2.30
Change
-$0.01 (-0.43%)
Updated
Apr 24 closing price
Capitalization
93.96M
33 days until earnings call
Ad is loading...

DTIL vs ORMP

Header iconDTIL vs ORMP Comparison
Open Charts DTIL vs ORMPBanner chart's image
Precision BioSciences
Price$5.50
Change-$0.18 (-3.17%)
Volume$85.41K
Capitalization58.03M
Oramed Pharmaceuticals
Price$2.30
Change-$0.01 (-0.43%)
Volume$24.56K
Capitalization93.96M
DTIL vs ORMP Comparison Chart
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. ORMP commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a StrongBuy and ORMP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (DTIL: $5.50 vs. ORMP: $2.30)
Brand notoriety: DTIL and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 49% vs. ORMP: 20%
Market capitalization -- DTIL: $58.03M vs. ORMP: $93.96M
DTIL [@Biotechnology] is valued at $58.03M. ORMP’s [@Biotechnology] market capitalization is $93.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, DTIL is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • DTIL’s TA Score: 4 bullish, 5 bearish.
  • ORMP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than DTIL.

Price Growth

DTIL (@Biotechnology) experienced а +9.56% price change this week, while ORMP (@Biotechnology) price change was +6.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

DTIL is expected to report earnings on Mar 26, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($94M) has a higher market cap than DTIL($58M). ORMP has higher P/E ratio than DTIL: ORMP (20.91) vs DTIL (5.29). DTIL YTD gains are higher at: 44.357 vs. ORMP (-4.959). DTIL has higher annual earnings (EBITDA): 18.8M vs. ORMP (9.44M). ORMP has more cash in the bank: 142M vs. DTIL (101M). ORMP has less debt than DTIL: ORMP (429K) vs DTIL (30.3M). DTIL has higher revenues than ORMP: DTIL (75.1M) vs ORMP (0).
DTILORMPDTIL / ORMP
Capitalization58M94M62%
EBITDA18.8M9.44M199%
Gain YTD44.357-4.959-895%
P/E Ratio5.2920.9125%
Revenue75.1M0-
Total Cash101M142M71%
Total Debt30.3M429K7,063%
FUNDAMENTALS RATINGS
DTIL vs ORMP: Fundamental Ratings
DTIL
ORMP
OUTLOOK RATING
1..100
1511
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4180
PRICE GROWTH RATING
1..100
6070
P/E GROWTH RATING
1..100
10040
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DTIL's Valuation (38) in the Biotechnology industry is in the same range as ORMP (67) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew similarly to ORMP’s over the last 12 months.

DTIL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew similarly to ORMP’s over the last 12 months.

DTIL's SMR Rating (41) in the Biotechnology industry is somewhat better than the same rating for ORMP (80) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew somewhat faster than ORMP’s over the last 12 months.

DTIL's Price Growth Rating (60) in the Biotechnology industry is in the same range as ORMP (70) in the Pharmaceuticals Other industry. This means that DTIL’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for DTIL (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than DTIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILORMP
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAESY91.241.08
+1.20%
BAE Systems PLC
GLGDF1.26N/A
-0.19%
GoGold Resources, Inc.
SOTGY83.36-1.09
-1.29%
Sunny Optical Technology (Group) Co Ltd
NURAF37.57-1.07
-2.77%
Nomura Research Institute Ltd.
ECTM0.46-0.04
-7.48%
ECA Marcellus Trust I

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
-3.17%
AXON - DTIL
46%
Loosely correlated
+2.39%
ORMP - DTIL
41%
Loosely correlated
-0.43%
ARRY - DTIL
39%
Loosely correlated
+5.31%
RENB - DTIL
36%
Loosely correlated
-0.75%
COGT - DTIL
35%
Loosely correlated
+0.89%
More